Squarepoint Ops LLC

Position in ACHV — Achieve Life Sciences, Inc.

CIK 1642575 NEW YORK, NY

Position in ACHV

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$57,794

-$760,292 QoQ

Shares Held

19,658

-88.1% QoQ

Ownership

0.019%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#50

of 81 holders

Holding Since

Sep 2020

9 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Squarepoint Ops LLC holds $1,099,505,720 across 232 Biotechnology names. ACHV ranks #211 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	426,723	$141,189,839
2	REGN	Regeneron Pharmaceuticals, Inc.	162,814	$125,796,608
3	RPRX	Royalty Pharma plc	1,349,516	$64,736,282
4	IONS	Ionis Pharmaceuticals Inc	695,276	$52,208,274
5	BBIO	BridgeBio Pharma, Inc.	556,324	$41,312,620
6	MDGL	Madrigal Pharmaceuticals, Inc.	52,884	$27,683,187
7	ARQT	Arcutis Biotherapeutics, Inc.	1,103,490	$25,998,224
8	FOLD	AMICUS THERAPEUTICS, INC.	1,705,829	$24,666,287

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$57,794	19,658	-88.1%	Shares	Defined	2026-05-15
2025-12-31	$818,086	164,605	-55.9%	Shares	Defined	2026-02-13
2025-09-30	$1,175,198	373,079	+2676.5%	Shares	Defined	2025-11-14
2025-06-30	$30,367	13,437	-23.3%	Shares	Defined	2025-08-27
2024-12-31	$61,666	17,519	-24.2%	Shares	Defined	2025-02-14
2023-12-31	$95,192	23,105	+85.2%	Shares	Defined	2024-02-14
2023-09-30	$53,638	12,474	-43.2%	Shares	Defined	2023-11-14
2023-06-30	$114,034	21,972	+117.7%	Shares	Defined	2023-08-14
2020-09-30	$84,478	10,093	—	Shares	Defined	2020-11-16
No filing history on record for this holder in this stock.